AzTrials
AzTrials

Childhood ObesityNCT02037490

Grow2Gether Pilot Study

A study testing Grow2Gether in people with Childhood Obesity, run by Children's Hospital of Philadelphia at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a randomized controlled pilot trial of a peer-based, social media intervention to prevent obesity in infants. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Childhood Obesity
What is being tested?
Grow2Gether
Could I receive a placebo?
No, everyone receives an active treatment
How many people
172 participants
Where
2 sitesUnited States
Study dates
Mar 2014to Oct 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Receiving prenatal care from Hospital of the University of Pennsylvania (HUP) obstetrics practices
  • Age 18 years and older
  • Able to provide informed consent
  • Able to speak, read and write in English
  • Enrolled in Medicaid at the time of study enrollment
  • Overweight or obese (BMI ≥ 25, calculated using height and weight recorded at a prenatal visit prior to 14 weeks of pregnancy)
Show all 10Show fewer
  • In ≥ 20th week of pregnancy
  • Plan to receive their child's primary care services from Children's Hospital of Philadelphia (CHOP) Care Network
  • Own a smartphone with both a data and text plan
  • Able to use their phone to obtain photographs and videos prior to enrollment

Who cannot join

  • Current diagnosis or history of major mental illness, as indicated in medical record by notation of (1) diagnosis or history of condition (2) current use or history of antidepressants or other psychotropic medication, or (3) referral to, or under care of a psychiatrist.
  • Multiple pregnancy (twins, triplets, etc.)
  • Severe morbidity (significant cardiac disease, significant organ dysfunction, transplant recipient, etc.)

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104

  • The Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

Official title: Grow2Gether: Pilot Trial of a Peer-Based Social Media Intervention to Promote Healthy Growth During Infancy

This is a randomized controlled pilot trial of a peer-based, social media intervention to prevent obesity in infants.

Read the detailed description

This novel intervention, delivered to mothers primarily through private Facebook groups, will promote behavior change through peer and self-modeling photo/video activities.

In this study, investigators will implement the intervention with small peer groups of 6-12 mothers, beginning during the 3rd trimester of pregnancy. Investigators will assess feasibility and acceptability of the intervention, and explore its impact on outcomes, particularly behaviors associated with healthy growth.

Being tested
Grow2Gether
Keywords
Infants, Mothers, Social media, Obesity prevention
Medical subject headings
Pediatric Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Grow2GetherBehavioural

    Participants in this intervention will:

    Participate in Facebook group of 6-12 peers for about 8 months, led by a professional group mentor.

    Complete an intervention video activity approximately weekly:

    1. View educational videos addressing topics related to healthy infant growth
    2. Create photos/videos modeling healthy behaviors and post them to the group
    3. Provide and receive feedback on posts
    4. Be encouraged to share information with key caregivers of their child

    Attend group party soon after enrollment, to meet peers and group leader in person.

Study groups in NCT02037490
Study groupRoleWhat they receive
Grow2Gether InterventionExperimentalParticipants in the intervention group will: * Participate in the Grow2Gether intervention * Receive text message reminders, 1) to schedule recommended primary care visits for their infant, and 2) to attend appointments scheduled in CHOP Care Network.
Receives: Behavioral: Grow2Gether
ControlNo interventionParticipants in the control group will: * Receive text message reminders, 1) to schedule recommended primary care visits for their infant, and 2) to attend appointments scheduled in CHOP Care Network.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intervention Acceptability Survey

    Satisfaction with the overall intervention will be assessed for mothers using a standard survey. Subjects will be asked a series of open-ended and Likert-scaled questions. Additionally, participants with certain characteristics (such as relatively high or low rates of group participation) will be purposively selected for brief semi-structured interviews based on the survey content to further elucidate their opinion of the intervention.

    Measured: After (within 31 days of) the 25th/final week of the postnatal intervention curriculum. (Approximately 8 months from each peer group's start.)

  2. Study population eligibility and interest

    • Proportion of all mothers contacted who meet enrollment criteria
    • Proportion of mothers meeting enrollment criteria who enroll

    These proportions will be calculated using study recruitment records.

    Measured: At enrollment

  3. Participant engagement

    • Proportion of enrolled mother-infant dyads that comply with intervention participation requirements
    • Proportion of enrolled mother-infant dyads that complete each weekly module activity
    • Proportion of enrolled mother-infant dyads that complete each study measure
    • Number and type of each participant's Facebook group interactions per week (posts, comments, "Likes")
    • Frequency, type, and content of each contact between moderator/study staff and each participant

    This study process data will be obtained from the Facebook group and study records at study end.

    Measured: Ongoing with study activities; to be completed after (within 31 days of) the 25th/final week of the postnatal intervention curriculum.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jan 2014 (estimated)
  2. Study startMar 2014
  3. Primary completionOct 2015
  4. Study completionOct 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
172 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02037490
Sponsor's protocol ID
13-010702
Status last verified
Jul 2016
First submitted
14 Jan 2014
Last updated
6 Jul 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Grow2Gether in people with Childhood Obesity, run by Children's Hospital of Philadelphia at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intervention Acceptability Survey (time frame: After (within 31 days of) the 25th/final week of the postnatal intervention curriculum. (Approximately 8 months from each peer group's start.)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in